pentobarbital will reduce the extent or impact of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Use of other treatment options is strongly suggested when linagliptin should be to be administered which has a CYP3A4 inducerpentobarbital will decrease the level or influence of atogepant by influencing hepat… Read More